-+ 0.00%
-+ 0.00%
-+ 0.00%

Venus Medtech targets China, EU regulatory filings for Venus-PowerX TAVR system

PUBT·07/23/2026 06:07:53
Listen to the news
Venus Medtech targets China, EU regulatory filings for Venus-PowerX TAVR system
  • Venus Medtech targets simultaneous regulatory filings in China and Europe for its Venus-PowerX TAVR system following completion of PREVAILS enrollment.
  • Submissions will seek CE marking in Europe and NMPA approval in China, supported by data from the confirmatory trial.
  • Commercial strategy centers on expanding international adoption using Latin America real-world evidence, while positioning Venus-PowerX for broader market access.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Venus MedTech HangZhou Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607230200PR_NEWS_EURO_ND__EN09981) on July 23, 2026, and is solely responsible for the information contained therein.